Skip to main content
Home

Breadcrumb

  1. Home
  2. News
  3. Search results
Displaying results 476 - 500 of 643 Clear search
Zyme Communications
Healthcare and Life Science 28 Jun 2022

Bio-Rad launches EconoFit Chromatography Column Packs

HERCULES, Calif.— Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of EconoFit Low-Pressure Prepacked Chromatography Column Packs to support resin screening experiments in the development of protein purification workflows.

Zyme Communications
Healthcare and Life Science 28 Jun 2022

H.E.L Group releases iso-BTC+ calorimeter for isothermal battery performance testing

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, announces the release of iso-BTC+, the latest addition to its battery testing portfolio.

Zyme Communications
Healthcare and Life Science 27 Jun 2022

Bio-Rad introduces CFX Opus Deepwell Real-Time PCR Detection System

Hercules, Calif. — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of the CFX Opus Deepwell Real-Time PCR Detection System to support researchers in developing nucleic acid detection assays.

Zyme Communications
Healthcare and Life Science 23 Jun 2022

FUJIFILM Irvine Scientific acquires exclusive license for artificial intelligence for IVF

Santa Ana, Calif., FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), announces it has exclusively licensed the intellectual property relating to artificial intelligence (AI) for image-based evaluation of human embryos to improve in-vitro fertilization (IVF) success rates

Zyme Communications
Healthcare and Life Science 21 Jun 2022

Optibrium receives further investment from Kester Capital

Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.

Zyme Communications
Healthcare and Life Science 20 Jun 2022

Yourgene Health Launches LightBench Detect for Fetal Fraction Enrichment

Manchester, UK - Yourgene Health plc, a leading international molecular diagnostics group, announces the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy (ISPD).

Zyme Communications
Healthcare and Life Science 15 Jun 2022

Global Access Diagnostics (GADx) formed to expand affordable access to advanced rapid diagnostic technologies

Bedford, UK - Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, formally introduces its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests.

Zyme Communications
Healthcare and Life Science 15 Jun 2022

seqWell appoints Dr Amy Liao to Board of Directors

Beverly, Mass  – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following…

Zyme Communications
Healthcare and Life Science 14 Jun 2022

Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer

Cambridge - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of superior and differentiated ADCs in the treatment of solid tumours where there is a high unmet need.

Zyme Communications
Healthcare and Life Science 13 Jun 2022

Bio-Rad Launches Foresight Pro Columns for Biotherapeutic Production

Helcules, Calif. - Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of its CHT™ prepacked Foresight Pro Columns, designed to support downstream process-scale chromatography applications across different stages of biological drug development and production. 

Zyme Communications
Healthcare and Life Science 13 Jun 2022

Innovate UK awards grant to Orbit Discovery to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery

The project will use microfluidic technology to improve efficiency of peptide therapeutics discovery for challenging drug targets.

Zyme Communications
Healthcare and Life Science 09 Jun 2022

Metrion Biosciences appoints Dr Benedetta Montagnini as Head of European Business Development

Expansion of European business development team supports next phase of growth for Metrion’s ion channel drug discovery services

Zyme Communications
Healthcare and Life Science 08 Jun 2022

Optibrium expands UK head office with new facilities on Cambridge Innovation Park

Optibrium™, a developer of software for drug discovery, announces the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and…

Zyme Communications
Healthcare and Life Science 07 Jun 2022

Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022

Hercules, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announces the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive…

Zyme Communications
Healthcare and Life Science 06 Jun 2022

Dotmatics strengthens leadership team as it continues to invest in organization capabilities and accelerate growth

Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, announces the addition of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer. The appointments further bolster the company’s executive team as the company extends the reach of its research and data solutions globally.

Zyme Communications
Healthcare and Life Science 31 May 2022

seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System

Beverly, Mass. And San Diego, Calif., - seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces a partnership with Element Biosciences Inc., developer of the Element AVITI™ System.

Zyme Communications
Healthcare and Life Science 27 May 2022

Bio-Rad launches CFX Duet Real-Time PCR System

Hercules, Calif. – Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of the CFX Duet Real-Time PCR System to support researchers in developing singleplex and duplex quantitative PCR (qPCR) assays.

Zyme Communications
Healthcare and Life Science 24 May 2022

CN Bio appoints Dr Paul Brooks as Chief Business Officer

Cambridge, UK : CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), announces the appointment of Dr Paul Brooks as Chief Business Officer.

Zyme Communications
Healthcare and Life Science 18 May 2022

FUJIFILM Irvine Scientific completes construction of Bioprocessing Innovation and Collaboration Center in China

New center opens in Suzhou New District, China, to bring local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug development.

Zyme Communications
Healthcare and Life Science 17 May 2022

Dotmatics supports Umicore Corporate R&D in processing of experimental data

Boston, MA, Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announces it has been selected by Umicore Corporate Research and Development, which is part of global materials technology and recycling company Umicore, as informatics partner for its Corporate R&D (CRD) digitalization project.

Zyme Communications
Healthcare and Life Science 16 May 2022

AffyXell expands its strategic partnership with GenScript ProBio

London and Wetherby, UK: Avacta Group plc, a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, is pleased to announce that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded its strategic partnership with GenScript ProBio, a leading…

Zyme Communications
26 Apr 2022

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

Boston, MA, — Dotmatics is announced as the formal name and brand for the combined entities of Insightful Science and Dotmatics. As the Insightful Science brand is retired, the new Dotmatics company is now inclusive of the Dotmatics’ enterprise scientific platform and many of scientists’ favorite applications including SnapGene, Geneious, and GraphPad Prism to offer end-to-end solutions for…

Zyme Communications
26 Apr 2022

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), introduces its PhysioMimix™ ‘in-a-box’ reagent kit for Non-alcoholic steatohepatitis (NASH), the most severe form of non-alcoholic fatty liver disease (NAFLD).

Zyme Communications
25 Apr 2022

Evonetix appoints Paul Beastall as Chair of Board of Directors

EVONETIX LTD the synthetic biology company bringing semiconductor technology to DNA synthesis, announces the appointment of Paul Beastall as Chair of the Board of Directors.

Zyme Communications
21 Apr 2022

Codexis and seqWell announce strategic investment and partnership initiation

Redwood City, Calif. and Beverly, Mass., Codexis Inc. and seqWell Inc. announces the initiation of a strategic partnership and investment to accelerate the commercialization of seqWell’s genomics workflow solutions.

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 18
  • Page 19
  • Current page 20
  • Page 21
  • Page 22
  • …
  • Next page ›
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS